The ROE as of November 2024 (TTM) for MediWound Ltd. (MDWD) is -75.57%

According to MediWound Ltd.’s latest financial reports and current stock price. The company's current ROE is -75.57%. This represents a change of 238.21% compared to the average of -22.35% of the last 4 quarters.

MediWound Ltd. (MDWD) Historical ROE (quarterly & annually)

How has MDWD ROE performed in the past?

The mean historical ROE of MediWound Ltd. over the last ten years is -63.58%. The current -75.57% ROE has changed 18.86% with respect to the historical average. Over the past ten years (40 quarters), MDWD's ROE was at its highest in in the June 2017 quarter at 1.25%. The ROE was at its lowest in in the June 2018 quarter at -404.37%.

MediWound Ltd. (MDWD) ROE by Quarter and Year

Discovering the peaks and valleys of MediWound Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MediWound Ltd. (MDWD) Average ROE

How has MDWD ROE performed in the past?

The current ROE of MediWound Ltd. (MDWD) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MediWound Ltd. (MDWD) ROE vs. Peers

How is MDWD’s ROE compared to its peers?

MediWound Ltd.’s ROE is less than Foghorn Therapeutics Inc. (140.34%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Sutro Biopharma, Inc. (-97.19%), greater than Dyadic International, Inc. (-145.95%), greater than Crinetics Pharmaceuticals, Inc. (-62.63%), less than Inhibrx Biosciences, Inc. (1.62%), greater than Merus N.V. (-45.38%), greater than Lyell Immunopharma, Inc. (-33.35%), greater than Kronos Bio, Inc. (-68.82%), greater than Aerovate Therapeutics, Inc. (-83.65%), greater than Keros Therapeutics, Inc. (-44.73%), greater than Syndax Pharmaceuticals, Inc. (-57.42%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than Replimune Group, Inc. (-52.15%), greater than Ocular Therapeutix, Inc. (-62.56%), greater than Veracyte, Inc. (-4.97%), greater than Avidity Biosciences, Inc. (-32.89%), greater than SpringWorks Therapeutics, Inc. (-56.13%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Nkarta, Inc. (-28.83%), greater than Generation Bio Co. (-92.86%), greater than Sana Biotechnology, Inc. (-71.60%),

Build a custom stock screener for MediWound Ltd. (MDWD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediWound Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MediWound Ltd. (MDWD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MediWound Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.